Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data

NeuroImage

Volumn 92, Issue , 2014, Pages 225-236

  Greve, Douglas N ^a,b   Svarer, Claus ^c   Fisher, Patrick M ^c   Feng, Ling ^c   Hansen, Adam E ^c   Baare, William ^c,d   Rosen, Bruce ^a,b   Fischl, Bruce ^a,b,e   Knudsen, Gitte M ^c,f  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c University of Copenhagen   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^f HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALTANSERIN; ALTANSERIN F 18; CARBON 11; CYSTEINE ETHYL ESTER TC 99M; FLUORINE 18; FLUORODEOXYGLUCOSE; MK 9470; MK 9470 F 18; PIB CARBON 11; RACLOPRIDE C 11; RADIOLIGAND; SB 207145; SB 207145 CARBON 11; SEROTONIN 4 ANTAGONIST; SETOPERONE; SETOPERONE F 18; UNCLASSIFIED DRUG; PIPERIDINE DERIVATIVE; RADIOPHARMACEUTICAL AGENT; SEROTONIN 4 RECEPTOR;

ADULT; ARTICLE; CEREBROSPINAL FLUID; GRAY MATTER; HUMAN; HUMAN EXPERIMENT; KINETICS; MALE; MASKING; NEUROIMAGING; NORMAL HUMAN; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; RELIABILITY; VOXEL BASED MORPHOMETRY; WHITE MATTER; ALGORITHM; ARTIFACT; BIOLOGICAL MODEL; BRAIN CORTEX; COMPUTER SIMULATION; DIAGNOSTIC USE; FEMALE; IMAGE ENHANCEMENT; METABOLIC CLEARANCE RATE; METABOLISM; PROCEDURES; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; YOUNG ADULT;

ADULT; ALGORITHMS; ARTIFACTS; CEREBRAL CORTEX; COMPUTER SIMULATION; FEMALE; HUMANS; IMAGE ENHANCEMENT; KINETICS; MALE; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL; PIPERIDINES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTORS, SEROTONIN, 5-HT4; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; YOUNG ADULT;

EID: 84895989937     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2013.12.021     Document Type: Article

References (64)

1. Becker J.A., Hedden T., Carmasin J., Maye J., Rentz D.M., Putcha D., Fischl B., Greve D.N., Marshall G.A., Salloway S., Marks D., Buckner R.L., Sperling R.A., Johnson K.A. Amyloid-beta associated cortical thinning in clinically normal elderly. Ann. Neurol. 2011, 69:1032-1042.
2. Bourgeat P., Chetelat G., Villemagne V.L., Fripp J., Raniga P., Pike K., Acosta O., Szoeke C., Ourselin S., Ames D., Ellis K.A., Martins R.N., Masters C.L., Rowe C.C., Salvado O. Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia. Neurology 2010, 74:121-127.
3. Chetelat G., Desgranges B., de la Sayette V., Viader F., Berkouk K., Landeau B., Lalevee C., Le Doze F., Dupuy B., Hannequin D., Baron J.C., Eustache F. Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment. Brain 2003, 126:1955-1967.
4. Chetelat G., Desgranges B., Landeau B., Mezenge F., Poline J.B., de la Sayette V., Viader F., Eustache F., Baron J.C. Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease. Brain 2008, 131:60-71.
5. Curiati P.K., Tamashiro-Duran J.H., Duran F.L., Buchpiguel C.A., Squarzoni P., Romano D.C., Vallada H., Menezes P.R., Scazufca M., Busatto G.F., Alves T.C. Age-related metabolic profiles in cognitively healthy elders: results from a voxel-based [18F]fluorodeoxyglucose-positron-emission tomography study with partial volume effects correction. AJNR Am. J. Neuroradiol. 2011, 32:560-565.
6. Dale A.M., Fischl B., Sereno M.I. Cortical surface-based analysis I: segmentation and surface reconstruction. Neuroimage 1999, 9:179-194.
7. Desikan R.S., Segonne F., Fischl B., Quinn B.T., Dickerson B.C., Blacker D., Buckner R.L., Dale A.M., Maguire R.P., Hyman B.T., Albert M.S., Killiany R.J. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006, 31:968-980.
8. Dickerson B., Salat D., Bates J., Atiya M., Killiany R., Greve D., Dale A., Stern C., Blacker D., Albert M.S., RA S. Medial temporal lobe function and structure in mild cognitive impairment. Ann. Neurol. 2004, 56:27-35.
9. Dickerson B.C., Bakkour A., Salat D.H., Feczko E., Pacheco J., Greve D.N., Grodstein F., Wright C.I., Blacker D., Rosas H.D., Sperling R.A., Atri A., Growdon J.H., Hyman B.T., Morris J.C., Fischl B., Buckner R.L. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb. Cortex 2009, 19:497-510.
10. Dickerson B.C., Salat D.H., Greve D.N., Chua E.F., Rand-Giovannetti E., Rentz D.M., Bertram L., Mullin K., Tanzi R.E., Blacker D., Albert M.S., Sperling R.A. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology 2005, 65:404-411.
11. Erlandsson K., Buvat I, Pretorius P.H, Thomas B.A, Hutton B.F A review of partial volume correction techniques for emission tomography and their applications in neurology, cardiology and oncology. Physics in medicine and biology 2012, 57(21):R119.
12. Fischl B., Dale A.M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc. Natl. Acad. Sci. 2000, 97:11044-11049.
13. Fischl B., Salat D.H., Albert M., Dieterich M., Haselgrove C., Kouwe A.v.d., Killiany R., Kennedy D., Klaveness S., Montillo A., Makris N., Rosen B., Dale A.M. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002, 33:341-355.
14. Fischl B., Sereno M.I., Dale A.M. Cortical surface-based analysis. II: inflation, flattening, and a surface-based coordinate system. Neuroimage 1999, 9:195-207.
15. Fischl B., Sereno M.I., Tootell R.B., Dale A.M. High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum. Brain Mapp. 1999, 8:272-284.
16. Fischl B., van der Kouwe A., Destrieux C., Halgren E., Segonne F., Salat D.H., Busa E., Seidman L.J., Goldstein J., Kennedy D., Caviness V., Makris N., Rosen B., Dale A.M. Automatically parcellating the human cerebral cortex. Cereb. Cortex 2004, 14:11-22.
17. Fisher P.M., Holst K.K., Mc Mahon B., Haahr M.E., Madsen K., Gillings N., Baare W.F., Jensen P.S., Knudsen G.M. 5-HTTLPR status predictive of neocortical 5-HT4 binding assessed with [(11)C]SB207145 PET in humans. Neuroimage 2012, 62:130-136.
18. Friston K.J., Worsley K.J., Frackowiak R.S.J., Mazziotta J.C., Evans A.C. Assessing the significance of focal activations using their spatial extent. Hum. Brain Mapp. 1993, 1:210-220.
19. Greve D., Fischl B. Accurate and robust brain image alignment using boundary-based registration. Neuroimage 2009, 48:63-72.
20. Haahr M.E., Fisher P., Holst K., Madsen K., Jensen C.G., Marner L., Lehel S., Baare W., Knudsen G., Hasselbalch S. The 5-HT(4) receptor levels in hippocampus correlates inversely with memory test performance in humans. Hum. Brain Mapp. 2012, 34:3066-3074.
21. Haahr M.E., Rasmussen P.M., Madsen K., Marner L., Ratner C., Gillings N., Baare W.F., Knudsen G.M. Obesity is associated with high serotonin 4 receptor availability in the brain reward circuitry. Neuroimage 2012, 61:884-888.
22. Hagler D.J., Riecke L., Sereno M.I. Parietal and superior frontal visuospatial maps activated by pointing and saccades. Neuroimage 2007, 35:1562-1577.
23. Haltia L.T., Rinne J.O., Merisaari H., Maguire R.P., Savontaus E., Helin S., Nagren K., Kaasinen V. Effects of intravenous glucose on dopaminergic function in the human brain in vivo. Synapse 2007, 61:748-756.
24. Holzel B.K., Hoge E.A., Greve D.N., Gard T., Cresswell J.D., Brown K.W., Lazar S.W. Neural mechanisms of symptom improvements in generalized anxiety disorder following mindfulness training. Neuroimage Clin. 2013, 2:448-458.
25. Hurlemann R., Matusch A., Kuhn K.U., Berning J., Elmenhorst D., Winz O., Kolsch H., Zilles K., Wagner M., Maier W., Bauer A. 5-HT2A receptor density is decreased in the at-risk mental state. Psychopharmacology (Berl.) 2008, 195:579-590.
26. Hutton B.F., Thomas B.A., Erlandsson K., Bousse A., Reilhac-Laborde A., Kazantsev D., Pedemonte S., Vunckx K., Arridge S., Ourselin S. What approach to brain partial volume correction is best for PET/MRI?. Nucl. Inst. Methods Phys. Res. A 2013, 29-33.
27. Ichise M., Ballinger J.R., Golan H., Vines D., Luong A., Tsai S., Kung H.F. Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT. J. Nucl. Med. 1996, 37:513-520.
28. Ichise M., Liow J.S., Lu J.Q., Takano A., Model K., Toyama H., Suhara T., Suzuki K., Innis R.B., Carson R.E. Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J. Cereb. Blood Flow Metab. 2003, 23:1096-1112.
29. Inoue K., Ito H., Goto R., Nakagawa M., Kinomura S., Sato T., Sato K., Fukuda H. Apparent CBF decrease with normal aging due to partial volume effects: MR-based partial volume correction on CBF SPECT. Ann. Nucl. Med. 2005, 19:283-290.
30. Jovicich J., Czanner S., Greve D., Haley E., van der Kouwe A., Gollub R., Kennedy D., Schmitt F., Brown G., Macfall J., Fischl B., Dale A. Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. Neuroimage 2006, 30:436-443.
31. Kalpouzos G., Chetelat G., Baron J.C., Landeau B., Mevel K., Godeau C., Barre L., Constans J.M., Viader F., Eustache F., Desgranges B. Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging. Neurobiol. Aging 2009, 30:112-124.
32. Kalpouzos G., Chetelat G., Landeau B., Clochon P., Viader F., Eustache F., Desgranges B. Structural and metabolic correlates of episodic memory in relation to the depth of encoding in normal aging. J. Cogn. Neurosci. 2009, 21:372-389.
33. Kochunov P., Ramage A.E., Lancaster J.L., Robin D.A., Narayana S., Coyle T., Royall D.R., Fox P. Loss of cerebral white matter structural integrity tracks the gray matter metabolic decline in normal aging. Neuroimage 2009, 45:17-28.
34. Kraus C., Hahn A., Savli M., Kranz G.S., Baldinger P., Hoflich A., Spindelegger C., Ungersboeck J., Haeusler D., Mitterhauser M., Windischberger C., Wadsak W., Kasper S., Lanzenberger R. Serotonin-1A receptor binding is positively associated with gray matter volume-a multimodal neuroimaging study combining PET and structural MRI. Neuroimage 2012, 63:1091-1098.
35. Lammertsma A.A., Bench C.J., Hume S.P., Osman S., Gunn K., Brooks D.J., Frackowiak R.S. Comparison of methods for analysis of clinical [11C]raclopride studies. J. Cereb. Blood Flow Metab. 1996, 16:42-52.
36. Lammertsma A.A., Hume S.P. Simplified reference tissue model for PET receptor studies. Neuroimage 1996, 4:153-158.
37. Logan J., Fowler J.S., Volkow N.D., Wolf A.P., Dewey S.L., Schlyer D.J., MacGregor R.R., Hitzemann R., Bendriem B., Gatley S.J., et al. Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J. Cereb. Blood Flow Metab. 1990, 10:740-747.
38. Marner L., Gillings N., Comley R.A., Baare W.F., Rabiner E.A., Wilson A.A., Houle S., Hasselbalch S.G., Svarer C., Gunn R.N., Laruelle M., Knudsen G.M. Kinetic modeling of 11C-SB207145 binding to 5-HT4 receptors in the human brain in vivo. J. Nucl. Med. 2009, 50:900-908.
39. Marner L., Gillings N., Madsen K., Erritzoe D., Baare W.F., Svarer C., Hasselbalch S.G., Knudsen G.M. Brain imaging of serotonin 4 receptors in humans with [11C]SB207145-PET. Neuroimage 2010, 50:855-861.
40. Matsuda H., Kanetaka H., Ohnishi T., Asada T., Imabayashi E., Nakano S., Katoh A., Tanaka F. Brain SPET abnormalities in Alzheimer's disease before and after atrophy correction. Eur. J. Nucl. Med. Mol. Imaging 2002, 29:1502-1505.
41. Matsuda H., Ohnishi T., Asada T., Li Z.J., Kanetaka H., Imabayashi E., Tanaka F., Nakano S. Correction for partial-volume effects on brain perfusion SPECT in healthy men. J. Nucl. Med. 2003, 44:1243-1252.
42. Meltzer C.C., Leal J.P., Mayberg H.S., Wagner H.N., Frost J.J. Correction of PET data for partial volume effects in human cerebral cortex by MR imaging. J. Comput. Assist. Tomogr. 1990, 14:561-570.
43. Meltzer C.C., Zubieta J.K., Links J.M., Brakeman P., Stumpf M.J., Frost J.J. MR-based correction of brain PET measurements for heterogeneous gray matter radioactivity distribution. J. Cereb. Blood Flow Metab. 1996, 16:650-658.
44. Mevel K., Desgranges B., Baron J.C., Landeau B., De la Sayette V., Viader F., Eustache F., Chetelat G. Detecting hippocampal hypometabolism in mild cognitive impairment using automatic voxel-based approaches. Neuroimage 2007, 37:18-25.
45. Muller-Gartner H.W., Links J.M., Prince J.L., Bryan R.N., McVeigh E., Leal J.P., Davatzikos C., Frost J.J. Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J. Cereb. Blood Flow Metab. 1992, 12:571-583.
46. Park H.J., Lee J.D., Chun J.W., Seok J.H., Yun M., Oh M.K., Kim J.J. Cortical surface-based analysis of 18F-FDG PET: measured metabolic abnormalities in schizophrenia are affected by cortical structural abnormalities. Neuroimage 2006, 31:1434-1444.
47. Protas H.D., Huang S.C., Kepe V., Hayashi K., Klunder A., Braskie M.N., Ercoli L., Bookheimer S., Thompson P.M., Small G.W., Barrio J.R. FDDNP binding using MR derived cortical surface maps. Neuroimage 2010, 49:240-248.
48. Quarantelli M., Berkouk K., Prinster A., Landeau B., Svarer C., Balkay L., Alfano B., Brunetti A., Baron J.C., Salvatore M. Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction. J. Nucl. Med. 2004, 45:192-201.
49. Rousset O., Rahmim A., Alavi A., Zaidi H. Partial volume correction strategies in PET. PET Clinics 2007, 2:235-249.
50. Rousset O.G., Ma Y., Evans A.C. Correction for partial volume effects in PET: principle and validation. J. Nucl. Med. 1998, 39:904-911.
51. Salat D.H., Buckner R.L., Snyder A.Z., Greve D.N., Desikan R.S., Busa E., Morris J.C., Dale A.M., Fischl B. Thinning of the cerebral cortex in aging. Cereb. Cortex 2004, 14:721-730.
52. Samuraki M., Matsunari I., Chen W.P., Yajima K., Yanase D., Fujikawa A., Takeda N., Nishimura S., Matsuda H., Yamada M. Partial volume effect-corrected FDG PET and grey matter volume loss in patients with mild Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging 2007, 34:1658-1669.
53. Schadwinkel S., Gutschalk A. Transient bold activity locked to perceptual reversals of auditory streaming in human auditory cortex and inferior colliculus. J. Neurophysiol. 2011, 105:1977-1983.
54. Segonne F., Dale A.M., Busa E., Glessner M., Salat D., Hahn H.K., Fischl B. A hybrid approach to the skull stripping problem in MRI. Neuroimage 2004, 22:1060-1075.
55. Segonne F., Pacheco J., Fischl B. Geometrically accurate topology-correction of cortical surfaces using nonseparating loops. IEEE Trans. Med. Imaging 2007, 26:518-529.
56. Strother s, La Conte S., Hansen L.K., Anderson J., Zhang J., Pulapura S., Rottenberg D.A. Optimizing the fMRI data-processing pipeline using prediction and reproducibility performance metrics: I. A preliminary group analysis. Neuroimage 2004, 23:S196-S207.
57. Sureau F.C., Reader A.J., Comtat C., Leroy C., Ribeiro M.J., Buvat I., Trebossen R. Impact of image-space resolution modeling for studies with the high-resolution research tomograph. J. Nucl. Med. 2008, 49:1000-1008.
58. Thomas B.A., Erlandsson K., Modat M., Thurfjell L., Vandenberghe R., Ourselin S., Hutton B.F. The importance of appropriate partial volume correction for PET quantification in Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging 2012, 38:1104-1119.
59. Uchida H., Chow T.W., Mamo D.C., Kapur S., Mulsant B.H., Houle S., Pollock B.G., Graff-Guerrero A. Effects of aging on 5-HT(2A) R binding: a HRRT PET study with and without partial volume corrections. Int. J. Geriatr. Psychiatry 2011, 26:1300-1308.
60. Van Laere K., Goffin K., Casteels C., Dupont P., Mortelmans L., de Hoon J., Bormans G. Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET. Neuroimage 2008, 39:1533-1541.
61. Varnas K., Halldin C., Pike V.W., Hall H. Distribution of 5-HT4 receptors in the postmortem human brain-an autoradiographic study using [125I]SB 207710. Eur. Neuropsychopharmacol. 2003, 13:228-234.
62. Woods R.P., Cherry S.R., Mazziotta J.C. Rapid automated algorithm for aligning and reslicing PET images. J. Comput. Assist. Tomogr. 1992, 16:620-633.
63. Worsley K.J., Marrett S., Neelin P., Evans A.C. Searching scale space for activation in PET images. Hum. Brain Mapp. 1996, 4:74-90.
64. Yanase D., Matsunari I., Yajima K., Chen W., Fujikawa A., Nishimura S., Matsuda H., Yamada M. Brain FDG PET study of normal aging in Japanese: effect of atrophy correction. Eur. J. Nucl. Med. Mol. Imaging 2005, 32:794-805.